TSLA
Tesla
-- 431.660 RGTI
Rigetti Computing
-- 17.0800 NVDA
NVIDIA
-- 137.010 LAES
SEALSQ Corp
-- 9.080 PLTR
Palantir
-- 79.080 
Ligand Pharmaceuticals' high P/E ratio may be plausible with...
Ligand Pharmaceuticals' high P/E ratio may be plausible with outstanding growth. Its promising future earnings outlook may prevent investors from selling stocks. Unless earnings decline, the current P/E ratio could support the share price.
Investors Appear Satisfied With Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Prospects
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment